Asian Journal of Research in Pharmaceutical Sciences
  • Year: 2023
  • Volume: 13
  • Issue: 2

Hepatocellular Carcinoma: A Review

  • Author:
  • Dhandhukiya Manavkumar Kanubhai*, Saiyed Musaratafrin Sabirali
  • Total Page Count: 9
  • Published Online: Oct 7, 2023
  • Page Number: 171 to 179

Department of Pharmacology, A. R. College of Pharmacy and G. H. Patel Institute of Pharmacy, Vallabh Vidyanagar, Anand-388120

*Corresponding Author E-mail: musaratsaiyed40@gmail.com

Online Published on 07 October, 2023.

Abstract

Hepatocellular Carcinoma (HCC) is the most common primary liver malignancy and is a leading cause of cancer-related death worldwide. Several risk factors responsible for development of HCC are liver and biliary Cirrhosis, Alcohol consumption, Hepatitis B and C infection, exposure to carcinogenic substance like Aflatoxin and Arsenic, comorbid condition like Obesity and Diabetes etc. In this review we discus about risk factors, screening methods and stages of HCC. Multiple treatment availability such as Radiation therapy, Chemotherapy and Surgical procedures along with newer modalities like Targeted Drug Delivery System, use of nano technology, newer Immunomodulators and Radiofrequency Ablation. Continued improvement in both surgical and nonsurgical approaches has demonstrated significant benefits in overall survival.

Keywords

Hepatocellular Carcinoma, Immunomodulator, Nanotechnology, Radiofrequency ablation